A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).
Clinical trial NCT06412666 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06412666
- Sponsor
- Cytokinetics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-29
- Primary completion
- 2030-01-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.